MENU
+Compare
CATX
Stock ticker: ASE
AS OF
Jan 14, 04:59 PM (EDT)
Price
$2.62
Change
+$0.11 (+4.38%)
Capitalization
186.59M

CATX Perspective Therapeutics Forecast, Technical & Fundamental Analysis

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body... Show more

Industry: #Biotechnology
CATX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CATX with price predictions
Jan 13, 2026

CATX in upward trend: price expected to rise as it breaks its lower Bollinger Band on January 12, 2026

CATX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 48 cases where CATX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

CATX moved above its 50-day moving average on January 13, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CATX crossed bullishly above the 50-day moving average on December 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CATX advanced for three days, in of 270 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 163 cases where CATX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 49 cases where CATX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on January 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CATX as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CATX turned negative on January 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.770) is normal, around the industry mean (62.991). P/E Ratio (0.000) is within average values for comparable stocks, (38.209). CATX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.662). CATX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (0.000) is also within normal values, averaging (39.712).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CATX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CATX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
CATX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CATX is expected to report earnings to rise 1.09% to -35 cents per share on March 26

Perspective Therapeutics CATX Stock Earnings Reports
Q4'25
Est.
$-0.35
Q3'25
Missed
by $0.03
Q2'25
Est.
$-0.29
Q1'25
Beat
by $0.06
Q4'24
Missed
by $0.30
The last earnings report on November 10 showed earnings per share of -34 cents, missing the estimate of -31 cents. With 510.37K shares outstanding, the current market capitalization sits at 186.59M.
A.I. Advisor
published General Information

General Information

a producer of therapeutic radioactive isotopes

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2401 Elliott Avenue
Phone
+1 206 676-0900
Employees
119
Web
https://www.perspectivetherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANSNF0.06N/A
+6.89%
Anson Resources
NVZMF65.251.35
+2.11%
NOVONESIS A S
AGYTF0.11N/A
N/A
Allergy Therapeutics Plc.
CBULF0.03N/A
N/A
Gratomic Inc.
SBFFF26.85N/A
N/A
SBM Offshore NV

CATX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CATX has been closely correlated with STRR. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CATX jumps, then STRR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
+4.15%
STRR - CATX
88%
Closely correlated
-1.47%
SHC - CATX
36%
Loosely correlated
-0.05%
NVCR - CATX
34%
Loosely correlated
-3.74%
SMLR - CATX
31%
Poorly correlated
-9.64%
MTD - CATX
31%
Poorly correlated
-0.48%
More

Groups containing CATX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
+4.15%
Medical/Nursing Services
industry (220 stocks)
1%
Poorly correlated
-0.32%
Health Services
industry (412 stocks)
-4%
Poorly correlated
-0.23%